Keith F. Fournier, MD

Associate Professor
Division of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, United States, United States

Presentation(s):

• 72: Predicting Severe Postoperative Complications After CRS-HIPEC: An Externally Validated Machine Learning Tool

  Thursday, March 21, 2024
  2:32pm – 2:42pm ET

• 68: Reliability of Recurrence-free Survival as an Efficacy Endpoint for Trials of Resected Colorectal Cancer Peritoneal Metastasis: Results from the PSOLARIS study group

  Friday, March 22, 2024
  3:06pm – 3:18pm ET

• P52: Updated Report of a Randomized Trial for Appendiceal Neoplasm Ten Years After Cytoreduction and HIPEC With Mitomycin vs. Oxaliplatin

  Saturday, March 23, 2024
  9:07am – 9:13am ET